Elmiron vision loss lawsuits are being filed at an increasing rate. Anyone that has been using the drug Elmiron to treat bladder conditions should be aware of the growing tide of concerns regarding the long-term side effects of this popular drug for interstitial cystitis.
After an initial wave of reports linking the use of Elmiron to serious vision impairment, the Food and Drug Administration (FDA) has recently stepped in and required the manufacturer of Elmiron to add a new warning label.
The new warning label alerts doctors and patients that Elmiron may cause a rare eye disease called pigmentary maculopathy that can cause vision impairment or blindness. The new warning label comes just as Elmiron vision loss lawsuits are already being filed across the country. Ultimately, when an Elmiron class action settlement is reached down the road, I predict a strong, unambiguous black box warning of the side effects that include vision loss.